Model
Edge
CytomX Therapeutics Inc.
0001601583
Filing Type
4
Filing Date
6/16/2020
Updated
6/17/20, 11:12 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership